PSA Vice President Professor Mark Naunton MPS[/caption]
Pharmacy prescribing trial expands to include skin conditions
With New South Wales recently expanding its pharmacy prescribing trial to include skin conditions, could other jurisdictions soon follow?
Clarity on aged care on-site pharmacist skills revealed
The Department of Health and Aged Care announce new credentialing requirements announced as pharmacists prepare to take on aged care roles.
Five practice pointers for dispensing Paxlovid
Pfizer’s COVID-19 treatment Paxlovid (nirmatrelvir and ritonavir) will be listed on the Pharmaceutical Benefits Scheme (PBS) from 1 May. Here’s what pharmacists need to know.
Liquorice: from sweet treat to modern treatment
Liquorice has been put to varied use since the beginning of recorded history. Today, largely unregulated ‘herbal’ remedies are sold, and people even use it as a shampoo.
The Ozempic shortage is over, says FDA
The Ozempic crisis is reportedly over in the United States. Could Australia's stock levels soon be replenished?
Making a difference in mental health
One in six Australians receive a mental health-related prescription each year.1 Almost half the population is set to experience a mental health condition in...
